Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | LP-168 |
Trade Name | |
Synonyms | LP168|LP 168 |
Drug Descriptions |
LP-168 is a selective BTK inhibitor with activity against wild-type BTK and BTK C481S, potentially inducing cytotoxicity in tumor cells and leading to antitumor activity (Blood (2023) 142 (Supplement 1): 416, Blood (2023) 142 (Supplement 1): 4400). |
DrugClasses | BTK inhibitor 37 |
CAS Registry Number | NA |
NCIT ID | C202999 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
LP-168 | LP-168 | 0 | 1 |